1.Ngan HYS, Seckl MJ, Berkowitz RS, et al. Update on the diagnosis and management of gestational trophoblastic disease. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2018, 143 Suppl 2: 79-85.

2.Jiang F, Wan XR, Xu T, et al. Evaluation and suggestions for improving the FIGO 2000 staging criteria for gestational trophoblastic neoplasia: A ten-year review of 1420 patients. Gynecologic oncology, 2018, 149 (3): 539-544.

3.Yang J, Zong L, Wang J, et al. Epithelioid Trophoblastic Tumors: Treatments, Outcomes, and Potential Therapeutic Targets. Journal of Cancer, 2019, 10 (1): 11-19.

4.Zong L, Yang J, Wang X, et al. Management and prognosis of patients with liver metastases from gestational trophoblastic neoplasia: a retrospective cohort study. Cancer management and research, 2018, 10: 557-563.

5.Jiang F, Xiang Y, Guo LN. Laparoscopic diagnosis and treatment of an isolated epithelioid trophoblastic tumor in recto-uterine pouch. The journal of obstetrics and gynaecology research, 2018, 44 (5): 960-965.

6.Wang X, Li Y, Yang J, et al. Identification and treatment of gestational trophoblastic neoplasia located in the cesarean scar. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2018, 141 (2): 222-227.

7.Wang X, Yang J, Li J, et al. Fertility-sparing uterine lesion resection for young women with gestational trophoblastic neoplasias: single institution experience. Oncotarget,2017, 8 (26): 43368-43375.

8.Yang JJ, Xiang Y, Wan XR, et al. Primary treatment of stage Ⅳ gestational trophoblastic neoplasia with floxuridine, dactinomycin, etoposide and vincristine (FAEV):A report based on our 10-year clinical experiences. Gynecol Oncol, 2016, 143 (1): 68-72.

9.Zhao J, Xiang Y, et al. Placental site trophoblastic tumor: A review of 108 cases and their implications for prognosis and treatment. Gynecol Oncol, 2016, 142 (1):102-108.

10.Li J, Yang JJ, Liu PF, et al. Clinical characteristics and prognosis of 272 postterm choriocarcinoma patients at Peking Union Medical College Hospital: a retrospective cohort study. BMC Cancer, 2016, 16: 347.

11.Xiao C, Yang J, Zhao J, et al. Management and prognosis of patients with brain metastasis from gestational trophoblastic neoplasia: a 24-year experience in Peking union medical college hospital. BMC Cancer, 2015,15 (1) : 318.

12.Shen Y, Yang J, Zhao J, et al. The switch from ER stressinduced apoptosis to autophagy via ROS-mediated JNK/p62 signals: A survival mechanism in methotrexateresistant choriocarcinoma cells. Exp Cell Res, 2015, 334(2): 207-218.

13.Zhao J, Xiang Y, Xiao C, et al. AKR1C3 overexpression mediates methotrexate resistance in choriocarcinoma cells. Int J Med Sci, 2014, 11 (11) : 1089-1097.

14.Yang J, Xiang Y, Wan X, et al. Analysis of the prognosis and related factors for patients with stage IV gestational trophoblastic neoplasia. Int J Gynecol Cancer, 2014, 24: 594-599.

15. Feng F, Hu H, Wu L, et al. Thoracotomy in refractory gestational trophoblastic neoplasia with lung metastasis after normalization of serum beta human chorionic gonadotropin (beta-hCG) with salvage chemotherapy. Onco Targets Ther, 2014, 7: 171-176.

16.Shen X, Xiang Y, Guo L, et al. Fertility-preserving treatment in young patients with placental site trophoblastic tumors. Int J Gynecol Cancer, 2012, 22: 869-874.

17.Shen X, Xiang Y, Guo L, et al. Analysis of clinicopathologic prognostic factors in 9 patients with epithelioid trophoblastic tumor. Int J Gynecol Cancer, 2011, 21: 1124-1130.

18.Feng F, Xiang Y, Wan X, et al. Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia. Ann Oncol, 2011, 22: 1588-1594.

19.Feng FZ, Xiang Y. Surgical management of chemoresistant gestational trophoblastic neoplasia. Expert Rev Anticancer Ther, 2010, 10: 71-80.

20.Cao Y, Xiang Y, Feng FZ, et al. Surgical resection in the management of pulmonary metastatic disease of gestational trophoblastic neoplasia. Int J Gynecol Cancer, 2009, 19: 798-801.

21.Feng FZ, Xiang Y, Cao Y. Metastasis of gestational trophoblastic neoplasia to the spinal canal. J Reprod Med, 2009, 54: 576-578.

22.Feng FZ, Xiang Y, et al. Prognosis of patients with relapsed and chemoresistant gestational thophoblastic neoplasia transferred to PUMC hospital. BJOG, 2010,117: 47-52.

23.Zhao J, Xiang Y, et al. Molecular genetic analysis of choriocarcinoma. Placenta, 2009, 30: 816-820.

24.Feng FZ, Xiang Y, et al. Clinical parameters predicting therapeutic response to surgical management in patients with chemoresistant gestational trophoblastic neoplasia. Gynecol Oncol, 2009, 113: 312-315.

25.Wan X, Yang X, Xiang Y, et al. Floxuidine-containing regiments in the treatment of gestational trophoblastic tumor. J Reprod Med, 2004, 49 (6): 453-456.

26.Xiang Y, Li L, Tian F, et al. Improving P-gp expression in human mononuclear cells in vitro transfected by multidrug resistance-1 mRNA. Chin Med Sci J, 2005, 20(1): 48-50.

27.Xiang Y, Sun Z, Wan X, et al. EMA/EP for chemorefractory gestational trophoblastic tomour. J Reprod Med,2004, 49: 443-446.

28.Xiang Y, Yang X, Du J, et al. The role of hysterectomy in the therapy of gestational trophoblastic tumor. Chin Med Sci J, 2000, 15 (1): 45-48.

29.Yang J, Xiang Y, Wan X, et al. The prognosis of gestational trophoblastic neoplasia patient with residual lung tumor after completing treatment. Gynecol Oncol, 2006, 103: 479-482.

30.Yang J, Xiang Y, Wan X, et al. Recurrent gestational trophoblastic tumor: Management and risk factors for recurrence, 2006, 103 (2): 587-590.

31.Yang JJ, Xiang Y, Yang XY, et al. Emergency craniotomy in patients with intracranial metastatic gestational trophoblastic tumor. Int J Gynaecol Obstet, 2005, 89 (1):35-38.

32.Zhao J, Moss J, Sebire NJ, et al. Analysis of the Chromosomal Region 19q13. 4 in Two Chinese Families with Recurrent Hydatidiform Mole. Hum Reprod,2006, 21 (2): 536-541.

33.Zhao J, Xiang Y, Wan XR, et al. Clinical and pathologic characteristics and prognosis of placental site trophoblastic tumor. J Reprod Med, 2006, 51 (12): 939-944.

34.Cole LA. Human chorionic gonadotropin tests. Expert Rev Mol Diagn, 2009, 9 (7): 721-747.

35.Cole LA. New discoveries on the biology and detection of human chorionic gonadotropin. Reprod Biol Endocrinol, 2009, 7: 8.

36.Cole LA. Human chorionic gonadotropin and associated molecules. Expert Rev Mol Diagn, 2009, 9 (1): 51-73.

37.Hamada AL, Nakabayashi K, Sato A, et al. Transfection of antisense chorionic gonadotropin beta gene into choriocarcinoma cells suppresses the cell proliferation and induces apoptosis. J Clin Endocrinol Metab, 2005,90 (8): 4873-4879.

38. Hertz R. Chemotherapeutic studies of hormoneproducing tumors of adrenal and trophoblastic origin. Mil Med, 1957, 120 (5): 342-346.

39.H. Z. Song, X. Y. Yang, Y. Xiang. Forty-five year’s experience of the treatment of choriocarcinoma and invasive mole. Inter J Gynecol Obstet, 1998, 60: S77-83.

40.Ross GT, Goldstein DP, Hertz R, et al. Sequential Use of Methotrexate and Actinomycin D in the Treatment of Metastatic Choriocarcinoma and Related Trophoblastic Diseases in Women. Am J Obstet Gynecol, 1965, 93:223-229.

41.Rushworth AG, Orr AH, Bagshawe KD. The concentration of HCG in the plasma and spinal fluid of patients with trophoblastic tumours in the central nervous system. Br J Cancer, 1968, 22 (2): 253-257.

42.Vaitukaitis JL, Braunstein GD, Ross GT. A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. Am J Obstet Gynecol, 1972, 113 (6): 751-758.

43.向阳, 宗丽菊. 免疫检查点抑制剂在妇科恶性肿瘤中的应用现状及展望. 中国实用妇科与产科杂志, 2019,01: 17-22.

44.向阳. 规范妊娠滋养细胞疾病的诊治关注患者围化疗期的生命质量. 中华妇产科杂志, 2018, 53 (6): 361-363.

45.蒋芳, 杨阳, 计鸣良, 等. 初治妊娠滋养细胞肿瘤患者的治疗效果分析——北京协和医院30 年回顾性队列研究. 中华妇产科杂志, 2018, 53 (6): 364-370.

46.蒋芳, 向阳. 对上皮样滋养细胞肿瘤的再认识. 协和医学杂志, 2018, 9 (01): 31-35.

47.李源, 杨隽钧, 向阳, 等. 10例上皮样滋养细胞肿瘤的临床诊治分析. 生殖医学杂志, 2018, 27 (06): 510-514.

48.向阳, 周琦, 吴小华, 等. 妊娠滋养细胞疾病诊断与治疗指南 (第4版). 中国实用妇科与产科杂志, 2018,34 (09): 994-1001.

49.计鸣良, 蒋诗阳, 赵峻, 等. 有高危因素的妊娠滋养细胞肿瘤初始化疗方案疗效评估. 中国实用妇科与产科杂志, 2018, 34 (04): 419-424.

50.陈纳泽, 赵峻, 向阳, 等. 含氟脲苷的多药联合化疗方案对妊娠滋养细胞肿瘤疗效评估研究. 中国实用妇科与产科杂志, 2017, 33 (05): 507-511.

51.孔雨佳, 向阳. 高危及耐药性妊娠滋养细胞肿瘤患者的治疗策略. 现代妇产科进展, 2017, 26 (07): 550-551, 555.

52.王晓雨, 王文泽, 杨隽钧, 等. CD105、BMP9 在绒癌组织中的表达及其临床病理意义. 现代妇产科进展,2017, 26 (09): 656-660.

53.赵峻, 向阳. 胎盘部位滋养细胞肿瘤的诊治. 中国实用妇科与产科杂志, 2017, 33 (04): 353-357.

54.蒋芳, 向阳, 万希润, 等. 妊娠滋养细胞肿瘤临床分期与预后评分系统 (FIGO 2000) 再评价. 中国实用妇科与产科杂志, 2016, 32 (12): 1198-1203.

55.杨隽钧, 任彤, 王丹, 等. 妊娠滋养细胞肿瘤泌尿系统及肾上腺转移患者的治疗及疗效分析. 中华妇产科杂志, 2014, 49 (10): 772-775.

56.赵静, 向阳. 绒癌耐药机制的研究现状. 中国癌症防治杂志, 2014, 6 (02): 105-108.

57.李洁, 向阳. 低危妊娠滋养细胞肿瘤化疗现状及耐药发生相关因素. 中国实用妇科与产科杂志, 2015, 31(11): 1052-1054.

58.雷呈志, 向阳, 等. 足月产后绒毛膜癌患者的临床特征与预后分析. 中华妇产科杂志, 2006, 41: 752-755.

59.杨隽钧, 向阳, 等. 妊娠滋养细胞肿瘤Ⅳ期患者的治疗与预后分析. 中华妇产科杂志, 2006, 41: 693-696.

60.杨隽钧, 向阳, 万希润, 等. 妊娠滋养细胞肿瘤患者的死亡原因及相关因素分析. 中华妇产科杂志, 2006,41: 403-407.

61.孙崟, 向阳, 万希润, 等. 绒毛膜癌复发的影响因素分析. 中华妇产科杂志, 2006, 41: 329-332.

62.万希润, 向阳, 杨秀玉, 等. FAEV化疗方案治疗高危型耐药性妊娠滋养细胞肿瘤的疗效分析. 中华妇产科杂志, 2006, 41 (2): 88-90.

63.杨隽钧, 向阳, 万希润, 等. 妊娠滋养细胞肿瘤复发的相关因素分析和治疗. 中华医学杂志, 2006, 86 (1):52-55.

64.杨隽钧, 向阳, 万希润, 等. 恶性滋养细胞肿瘤的疗效和预后因素分析. 现代妇产科进展, 2006, 15: 816-821.

65.冯凤芝, 向阳, 万希润, 等. 50岁以上妇女妊娠滋养细胞疾病的临床分析. 中华妇产科杂志, 2005, 40 (9):605-608.

66.钱海鹏, 向阳, 田方, 等. 人多药耐药基因mdr1野生型mRNA转导脐血干细胞提高其对化疗耐药性的体外研究. 肿瘤防治杂志, 2005, 12 (9): 641-644.

67.杨隽钧, 向阳, 杨秀玉, 等. 绒毛膜癌脑转移急诊行开颅手术的临床分析. 中华妇产科杂志, 2005, 40(5): 335-338.

68.张颖, 向阳, 任彤, 等. 恶性滋养细胞肿瘤肺转移患者肺叶切除术指征的探讨. 中华妇产科杂志, 2005,40 (2): 83-86.

69.向阳, 万希润, 孙智晶, 等. EMA/EP方案治疗耐药性滋养细胞肿瘤疗效的初步分析. 中华妇产科杂志,2005, 40 (2): 79-82.

70.张卫光, 冯凤芝, 向阳, 等. 人肿瘤坏死α基因对绒毛膜癌耐药细胞凋亡影响的体内研究. 解剖学报,2004, 35 (3): 268-271.

71.任彤, 向阳, 杨秀玉, 等. 肺叶切除术治疗滋养细胞肿瘤肺转移的价值. 中国医学科学院学报, 2003, 5: 18-421.

72.曹冬焱, 向阳, 杨秀玉, 等. 非妊娠性绒毛膜癌17例临床分析. 中华妇产科杂志, 2003, 38: 284-286.

73.冯凤芝, 向阳, 张卫光, 等. 人肿瘤坏死-α基因转导绒癌耐药细胞系体外耐药逆转的研究. 肿瘤, 2003,23 (4): 283-286.

74.冯凤芝, 向阳, 崔竹梅, 等. 转导人肿瘤坏死因子α基因对耐药性绒毛膜癌裸鼠移植瘤耐药性的逆转作用. 中华妇产科杂志, 2003, 38 (5): 294-297.

75.向阳. 耐药性滋养细胞肿瘤患者的诊断与处理. 中国妇产科临床杂志, 2003, 4: 13-15.

76.李雷, 向阳, 田方, 等. 采用多药耐药基因mRNA转染人单个核血细胞提高对化疗药物耐药性的体外研究. 中华医学杂志, 2002, 82 (12): 848-851.

77.万希润, 向阳, 杨秀玉, 等. 超选择性动脉栓塞术治疗恶性滋养细胞肿瘤灶大出血的疗效观察. 中华妇产科杂志, 2002, 37 (1): 5-7.

78.崔竹梅, 杨秀玉, 向阳, 等. IL-2基因转染逆转绒癌耐药细胞系多药耐药性. 基础医学与临床, 2001, 21(6): 523-526.

79.崔竹梅, 向阳, 杨秀玉, 等. 绒毛膜癌耐药细胞系的建立及获得性耐药机制的研究. 现代妇产科进展,2001, 10 (5): 332-335.

80.崔竹梅, 向阳, 杨秀玉, 等. 绒毛膜癌耐药细胞系的建立及人白细胞介素2基因转染后对其多药耐药性的逆转作用. 中华妇产科杂志, 2001, 36 (9):549-553.

81.向阳, 杨秀玉, 宋鸿钊, 等. 恶性滋养细胞肿瘤脑转移的疗效分析. 中华妇产科杂志, 2001, 36 (7): 417-420.